Anti-hyperproliferative therapies targeting hdgf

Details Anti-hyperproliferative therapies targeting hdgf Anti-hyperproliferative therapies targeting hdgf

C - Chemistry, Metallurgy

07

K

C07K 16/22 (2006.01) A61K 9/127 (2006.01) A61K 39/395 (2006.01) A61K 47/48 (2006.01) A61K 48/00 (2006.01) A61P 35/00 (2006.01) C07K 19/00 (2006.01) C12N 15/13 (2006.01) C12Q 1/68 (2006.01) G01N 33/543 (2006.01) G01N 33/574 (2006.01) C12N 15/11 (2006.01) G01N 33/58 (2006.01)

Patent

CA 2634783

The present invention provides methods of cancer therapy or diagnosis involving targeting hepatoma-derived growth factor (HDGF). In certain embodiments, an antibody and/or siRNA may be used to inhibit HDGF, optionally coupled to or combined with other cancer therapies.

La présente invention fournit des procédés de thérapie contre le cancer ou de diagnostic impliquant le ciblage d'un facteur de croissance dérivé de l'hépatome (HDGF). Dans certains modes de réalisation, un anticorps et/ou ARNsi peut être utilisé pour inhiber un HDGF, facultativement couplé ou combiné à d'autres thérapies contre le cancer.

Affiliated with

Also associated with

Rating

Anti-hyperproliferative therapies targeting hdgf does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Anti-hyperproliferative therapies targeting hdgf, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anti-hyperproliferative therapies targeting hdgf will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1628832